13.35
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt RDY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$13.44
Offen:
$13.26
24-Stunden-Volumen:
1.53M
Relative Volume:
0.94
Marktkapitalisierung:
$2.22B
Einnahmen:
$3.47B
Nettoeinkommen (Verlust:
$668.83M
KGV:
3.3269
EPS:
4.0127
Netto-Cashflow:
$253.46M
1W Leistung:
-1.84%
1M Leistung:
-9.80%
6M Leistung:
-20.73%
1J Leistung:
-11.76%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Vergleichen Sie RDY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RDY
Dr Reddys Laboratories Ltd Adr
|
13.35 | 2.22B | 3.47B | 668.83M | 253.46M | 4.0127 |
![]()
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-19 | Herabstufung | Nomura | Buy → Neutral |
2024-01-11 | Herabstufung | Jefferies | Buy → Underperform |
2023-08-29 | Herabstufung | HSBC Securities | Buy → Hold |
2023-05-18 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2023-03-17 | Hochstufung | BofA Securities | Neutral → Buy |
2023-01-30 | Eingeleitet | JP Morgan | Underweight |
2022-11-14 | Herabstufung | Credit Suisse | Neutral → Underperform |
2022-01-03 | Fortgesetzt | BofA Securities | Neutral |
2021-07-27 | Herabstufung | Credit Suisse | Outperform → Neutral |
2021-02-02 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-09-18 | Hochstufung | BofA Securities | Neutral → Buy |
2020-09-18 | Hochstufung | Investec | Sell → Hold |
2020-01-28 | Herabstufung | CLSA | Buy → Outperform |
2020-01-27 | Herabstufung | CLSA | Buy → Outperform |
2020-01-09 | Hochstufung | Citigroup | Sell → Buy |
2019-11-04 | Herabstufung | BofA/Merrill | Buy → Neutral |
2019-09-04 | Hochstufung | Credit Suisse | Underperform → Outperform |
2019-07-01 | Hochstufung | Macquarie | Neutral → Outperform |
2019-06-20 | Eingeleitet | Deutsche Bank | Hold |
2019-06-11 | Eingeleitet | Barclays | Equal Weight |
2019-05-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2019-02-19 | Hochstufung | CLSA | Outperform → Buy |
2019-01-17 | Herabstufung | Citigroup | Neutral → Sell |
2017-09-21 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2017-08-31 | Hochstufung | CLSA | Underperform → Outperform |
2017-07-28 | Herabstufung | CLSA | Underperform → Sell |
2016-07-27 | Herabstufung | HSBC Securities | Hold → Reduce |
2016-07-27 | Herabstufung | Jefferies | Hold → Underperform |
2016-02-10 | Hochstufung | Credit Agricole | Underperform → Buy |
2015-11-10 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Dr Reddys Laboratories Ltd Adr Aktie (RDY) Neueste Nachrichten
Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News
Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView
Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns
Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily
Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News
Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News
A look into Golar Lng (GLNG)’s deeper side - SETE News
Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily
Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily
Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater
LLY Stock Quote Price and Forecast - CNN
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times
Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business - Benzinga
Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register
Dr. Reddys Lab, Mankind Pharma, Adani Energy Solutions, Indus Towers—Earnings Estimates - NDTV Profit
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth - Moneycontrol
Week Ahead: Q3 Results, FII flow, Donald Trump inauguration, global cues among key market triggers for Sensex, Nifty - Mint
Infosys shares fall 4% after wage hike impact on margins overshadow guidance raise - CNBCTV18
Stock Market News Today highlights on January 16, 2025 : Stock exchanges ban fresh F&O positions in Kalyan Jewellers | Stock Market News - Mint
Dr. Reddy's Laboratories12 stocks trade against tide, hover near their 52-week high - The Economic Times
GAMMA Investing LLC Has $107,000 Position in Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World
Guess who’s the richest MLA in outgoing Delhi assembly? Hint – it’s NOT Kejriwal, Atishi or Sisodia | Mint - Mint
Dr Reddy Share Price Highlights : Dr Reddy closed today at ₹1374.1, up 1.73% from yesterday's ₹1350.75 | Stock Market News - Mint
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Asian Equities Traded in the US as ADRs Rise in Thursday Trading - MSN
Buy Dr Reddy's & IRB Infra shares; sell JSW Energy stock, says YES Securities - Business Today
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading - MSN
Where is Dr Reddy's Share Price Headed in 2025? - Equitymaster
Weekly Upgrades and Downgrades - InvestorPlace
Stock Market News Today Live Updates on December 20, 2024 : Top Gainers and Losers today on 20 December, 2024: Dr Reddys Laboratories, ICICI Bank, Tech Mahindra, Trent among most active stocks; Check full list here | Stock Market News - Mint
Dr Reddy’s shares jump over 4 per cent on upgrade by NomuraMarket News - The Financial Express
Zopiclone Market Forecast: Trends and Investment - openPR
Dr Reddy's Laboratories Share Price Live Updates: Disclosure Under Regulation 30 Of SEBI (LODR) Regulatio... - The Economic Times
Dr Reddy’s will top up base business with innovation in India: M V Ramana - BusinessLine
ADR, GDR Listings of Indian companies - Goodreturns
Asian Equities Traded in the US as American Depositary Receipts Edge Down in Wednesday Trading - MSN
NVO Stock Quote Price and Forecast - CNN
Dr Reddy's Labs tanks over 3% after USFDA inspects Hyderabad API facility - Business Standard
Stocks to watch on November 21: Adani Group stocks, Dr Reddy's, Godrej Properties, Tata Power, GRSE, UPL, Bharti Airtel - Upstox
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
Dr Reddy's shares fall 3% as pharma major receives 7 observations from USFDA; check details - Upstox
Asian Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - MSN
Jharkhand Elections Phase 2: Richest candidate declares assets worth Rs 402 cr – Check list of top 10 wealthiest candidates - The Financial Express
Finanzdaten der Dr Reddys Laboratories Ltd Adr-Aktie (RDY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):